New Stock Research Reports for June 28, 2016

Tuesday, June 28, 2016

Today's must-read reports are for Amazon (AMZN), AT&T (T) and Wal-Mart (WMT).

Amazon shares have lost some of their mojo lately, but this Zack Rank # 2 (Buy) rated stock remains well positioned for continued momentum, as confirmed by the recent positive revisions to EPS estimates. The analyst likes the company's leadership position in the ecommerce space on the back of innovation in delivery and logistics, wider product selection, device strategy, international expansion and the Prime membership program. The comapny has alos emerged as a 'cloud' leader through its Amazon Web Services (AWS) offering. (You can read the full research report on AMZN here.)

Zacks Rank # 2 (Buy) rated AT&T shares should continue their strong recent run on the back of operating mometnum, financial strength and perceived safety. In addition to its strong cellular franchise, the analyst likes the company's position in the U.S. pay-TV market post the DIRECTV purchase. Investments in the Mexican telecom market and fiber arena are other reasons for optimism. (You can read the full research report on T here.)

Analysts are raising their estimates for Wal-Mart on positive momentum in its U.S. comps and traffic, which appear to be benefiting from the company’s efforts to modernize its stores. The company is also making serious investments in its ecommerce platform, which is weighing on near-term profitability but holds a lot of long-term promose. (You can read the full research report on WMT here.)

Other noteworthy reports today include Apple (AAPL), Medtronic (MDT) and Glaxo’s (GSK).

Gelogis

 Brexit May Impact Apple (AAPL)  Medtronic (MDT) Gains from HeartWare Buy Glaxo (GSK) Topline Hit By Generics

You can find all of today's stock research reports here.

Sheraz Mian

Director of Research

Today’s Must Read

Cloud Business, Platform Approach to Boost Amazon’s (AMZN) Growth

AT&T (T) Looks Strong on Fiber Expansion

Wal-Mart (WMT) Driving Sales with Multiple Initiatives

Featured Reports

Apple (AAPL) May Not Be Immune from Brexit

The analyst thinks Apple’s expansion in high growth markets, loyal customer base and growing demand for services might be enough to overcome resulting demand woes.

Medtronic (MDT) to Boost Heart Failure Business with HeartWare Buy

The analyst believes the acquisition should provide a major boost to its heart failure business.

Brexit Could Impede Facebook’s (FB) Growth

Though Facebook’s user base is generating impressive revenues, Brexit may have eroded some of its growth potential, according to the covering analyst.

AXIR Consulting

GE (GE) Inks Deals to Divest US Restaurant Assets

GE is seeking to become a nimbler firm and will divest most of GE Capital’s restaurant franchise financing assets in the US.

Ford’s (F) Indonesian Dealers Seek Compensation

Ford’s Indonesian dealers are seeking $75 million in compensation as they will incur losses due to the company’s exit from the nation.

Sanofi (SNY)-Boehringer Ingelheim Agree to Swap Businesses

The deal marks Sanofi’s exit from the animal health market while strengthening its position in the consumer healthcare business. n

TOTAL (TOT) Grows in Qatar with 30% interest in Al-Shaheen Field

The analyst thinks TOTAL’s Middle East operations will expand further after its successful bidding for a 30% interest in Qatar’s Al-Shaheen oil field.n

New Upgrades

Charter Communications (CHTR) Gains from Time Warner Merger

The covering analyst thinks the Time Warner Cable and Bright House deals are likely to benefit Charter in terms of geographic expansion and operating cost synergies

Cost Saving Initiatives Boost Kimberly-Clark’s (KMB) Earnings Growth

Kimberly-Clark’s cost saving initiatives and continued product innovation has been driving earnings, according to the Zacks analyst.

NVIDIA’s (NVDA) Revenues to Receive a Fillip from Product Launches

The covering analyst thinks NVIDIA’s recently launched products are likely to capture a large share of the market soon due to their lower capital and operational costs advantages.

New Downgrades

Berkshire Hathaway’s (BRK.B) Exposure to Catastrophe Loss Worrying

The analyst believes Berkshire Hathaway is exposed to catastrophe losses, which is why its Property and Casualty underwriting results is exposed to volatility.

P&G Struggling with Sales, Margins Improving

Significant negative forex impact, weak volumes, divestitures and slowing market growth have been denting sales, according to the covering analyst.

Generics Continue to Weigh on Glaxo’s (GSK) Top-Line

The Zacks analyst stresses that Glaxo’s top line is under pressure given the presence of generic competition for several products and an expected decline in Advair sales.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report WAL-MART STORES (WMT): Free Stock Analysis Report AT&T INC (T): Free Stock Analysis Report MEDTRONIC (MDT): Free Stock Analysis Report GLAXOSMITHKLINE (GSK): Free Stock Analysis Report AMAZON.COM INC (AMZN): Free Stock Analysis Report APPLE INC (AAPL): Free Stock Analysis Report To read this article on Zacks.com click here. 

Read More

No Comments Yet

Leave a Reply